Skip to main content

Advances in Melanoma

TO REGISTER: Scroll down and select the Webinar component
ASDS Fellow Members and Residents: $49
Non-Members: $99

This educational activity covers indications and limitations of Mohs surgery for melanoma, new developments in surgery for melanoma, including wide excision, sentinel node biopsy, node dissection, metastasectomy, and neoadjuvant therapy in melanoma. CME: 1.00 AMA PRA Category 1 Credit™

Learning Objectives
At the conclusion of this activity, participants should be able to:

  • Describe the indications and limitations of Mohs surgery for melanoma
  • Recognize the indications for sentinel node biopsy and how they may be impacted by tumor genetic expression profiling
  • Define neoadjuvant therapy in melanoma and list at least two potential applications

Christopher J. Miller, MD
John T. Vetto, MD, FACS

The American Society for Dermatologic Surgery (ASDS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASDS designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.